Laurel A. Lagenaur
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 20, 2025 | NIH | SBIR Phase I Novel Antimicrobial Approach to Treat Chemoradiation Resistant Cervical Cancer by Selectively Inhibiting Lactobacillus iners | $296K | OSEL, INC. |
| Aug 3, 2021 | NIH | SBIR Phase II MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial | $464K | OSEL, INC. |
| Jul 27, 2020 | NIH | SBIR Phase II MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial | $1.0M | OSEL, INC. |
| Mar 22, 2016 | NIH | SBIR Phase I Development of a rapid point of care diagnostic,to monitor MucoCept-CVN, an HIV-targeted biotherapy, | $225K | OSEL, INC. |
| Jul 15, 2015 | NIH | SBIR Phase II Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies | $1.4M | OSEL, INC. |
Peer ranks
Federal funding#516
Awards as PI#417
Patents#273
Companies
- OSEL, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.